Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C

被引:0
|
作者
Sasaki, Shoichi [1 ]
Nirei, Kazushige [1 ]
Matsuoka, Shuniti [1 ]
Nakamura, Hitomi [1 ]
Moriyama, Mitsuhiko [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Gastroenterol & Hepatol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1281
引用
收藏
页码:383 / 384
页数:2
相关论文
共 50 条
  • [1] Incidence of Hepatocellular Carcinoma Reduced by Phlebotomy Treatment in Patients with Chronic Hepatitis C
    Nirei, Kazushige
    Matsuoka, Shuniti
    Nakamura, Hitomi
    Matsumura, Hiroshi
    Moriyama, Mitsuhiko
    [J]. INTERNAL MEDICINE, 2015, 54 (02) : 107 - 117
  • [2] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment
    Miyajima, I
    Sata, M
    Kumashiro, R
    Uchimura, Y
    Ide, T
    Suzuki, H
    Tanikawa, K
    [J]. ONCOLOGY REPORTS, 1998, 5 (01) : 201 - 204
  • [3] HEPATOCELLULAR CARCINOMA INCIDENCE IN CHRONIC HEPATITIS C PATIENTS ACCORDING TO ANTIVIRAL TREATMENT STATUS
    Purevsambuu, T.
    Bota, S.
    Hucke, F.
    Hofer, H.
    Ferenci, P.
    Sieghart, W.
    Peck-Radosavljevic, M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S446 - S447
  • [4] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    [J]. ONCOLOGY, 2002, 62 : 87 - 93
  • [5] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [6] Liver stiffness and the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Nakayama, Yuji
    Takeda, Tadashi
    Yasuda, Takahiro
    Nakaya, Mika
    Nakahara, Kenishi
    Fujii, Hideki
    Kobayashi, Sawako
    Iwai, Shuuji
    Enomoto, Masaru
    Tamori, Akihiro
    Sakaguchi, Hiroki
    Habu, Daiki
    Seki, Shuichi
    Kawada, Nonfumi
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A780 - A780
  • [7] The Incidence of Hepatocellular Carcinoma from Chronic Hepatitis C Patients Aft er Interferon Treatment
    Kikuchi, Kaoru
    Yamaguchi, Yutaka
    Yosida, Yukio
    Chinen, Kenji
    Kubota, Tomiaki
    Arashiro, Masayuki
    Shimabukuro, Yoshiki
    Keida, Yoshihide
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S135 - S135
  • [8] Erythropoietin use in patients on chronic hepatitis C treatment: Incidence of thromboembolic events and hepatocellular carcinoma
    Werner, Kristina T.
    Rosati, Marianne J.
    Vargas, Hugo E.
    Byrne, Thomas
    Rakela, Jorge L.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A843 - A843
  • [9] Meta-analysis: reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C
    Miyake, Yasuhiro
    Iwasaki, Yoshiaki
    Yamamoto, Kazuhide
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (04) : 989 - 996
  • [10] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283